NASDAQ
ADC Therapeutics S.A. (ADCT) has a free cash flow growth of 4.47% as of Friday, May 29, 2026. This represents a 113.91% increase compared to its 12-month average of -32.15%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.